Producing Ribonuclease Inhibitor in E. coli
Author Information
Author(s): Šiurkus Juozas, Neubauer Peter
Primary Institution: Thermo Fisher Scientific
Hypothesis
The redox conditions in the cytoplasm are an important target for process optimisation for the production of soluble and active ribonuclease inhibitor.
Conclusion
The study established an efficient recombinant process for ribonuclease inhibitor production, achieving a yield of 625 mg L-1 of active product.
Supporting Evidence
- Active ribonuclease inhibitor was produced at a yield of 625 mg L-1.
- The combination of DTT, low temperature, and GroELS coexpression significantly improved protein solubility and activity.
- High cell density cultivation techniques were effective for optimizing production factors.
Takeaway
Scientists figured out how to make a special protein in bacteria by changing the environment to help it fold correctly, which made a lot more of the protein.
Methodology
The study used a T7 RNA polymerase expression system in E. coli, optimizing conditions like temperature, reducing agents, and chaperonin coexpression.
Limitations
The study did not explore the effects of other potential chaperonins or different E. coli strains on ribonuclease inhibitor production.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website